Join the FDA and Health Canada for a pivotal regional public meeting on February 22, 2024, leading up to the ICH Biannual Assembly meeting scheduled for June 4-5, 2024.
About This Event
This webinar brings together industry leaders and regulatory experts to provide key updates and solicit input on ICH guidelines. Discuss recent milestones, including analytical validation, viral safety evaluation, and post-approval safety data management. Gain insights from presentations covering drug interaction studies, quality risk management, and general principles on plan, design, and analysis of pharmacoepidemiological studies. Take advantage of this opportunity to engage with renowned professionals and contribute to shaping global pharmaceutical standards.
Intended Audience
This meeting is intended for North American regulators, industry professionals, and stakeholders interested in ICH’s efforts to set global pharmaceutical standards. Professionals in relevant fields will receive certificates of attendance supporting continuing education.
Registration
Visit the official meeting page for additional information and to register now.
Please note that an external entity hosts this event.